Close Menu

Beckman Coulter

The agency is requesting sequencing services on both the 454 and Illumina platforms. Beckman Coulter and Macrogen are among the companies interested in submitting proposals.

The firm reported particularly strong growth for its clinical diagnostics segment, which posted 30 percent revenue growth.

Beckman Coulter's shares dropped around 7 percent after the firm disclosed that an ongoing issue surrounding its troponin test kits could lead to further restrictions on the test and may have a material impact on its results.

The Australian firm has taken aim at several firms in the research, molecular diagnostics, and agricultural genomics fields for allegedly infringing its patent covering methods of analyzing non-coding DNA sequences.

The Olympus Diagnostics business that Beckman Coulter acquired last summer provided a $120 million contribution for the fourth quarter. The firm beat analysts' consensus estimate, despite a drag from cash instrument sales during the quarter.

The firm will pay a dividend of $.18 per share and plans to buy back up to 1.5 million shares of its outstanding common stock.

The new service, which is available worldwide, expands Beckman Coulter Genomics' DNA sequencing applications portfolio and makes use of Genpathway's experience with chromatin immunoprecipitation.

The alliance will combine Beckman Coulter Genomics' sequencing capabilities with Genpathway's ChIP sequencing data and analysis.

The cuts follow a round of layoffs at the same facility late last year.

The automated benchtop system, called SPRIworks Fragment Library System I, is scheduled to be launched this quarter. It is capable of preparing up to 10 DNA libraries for the Illumina Genome Analyzer within five hours, according to Beckman.


The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.